For informational purposes only — not investment advice

← Back to signals

ALKT

ALKAMI TECHNOLOGY, INC.

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
2.1d↓-5.9%
as of 2026-10-30 · shares short vs 2026-09-30

News Summary

Neutral

Alkami rejected a sale after strategic review and committed to remaining independent, triggering a sharp 20% stock selloff despite Q3 revenue beating guidance (+19% YoY to $134.9M) and raised full-year guidance. The strategic review conclusion has created near-term uncertainty around client acquisition, though the company exited the review with a $56M ARR backlog and maintains strong subscription revenue growth (20% YoY).

Red flags

  • •Strategic review rejection triggered 20% stock decline; market clearly preferred sale option
  • •Q3 EPS missed badly: -$0.06 actual vs. +$0.20 consensus expectation despite revenue beat
  • •Strategic review cited as headwind slowing new client acquisitions in near term
  • •Activist investor Jana Partners continues engagement despite failed sale push, signaling ongoing governance pressure

Fund 13D/13G Filings (5)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Jana PartnersSC 13D/A−1.4M5.0%
+7.2% vs SPY
+1.9% abs
2026-10-30↗
Jana PartnersSC 13D/A+06.3%
-1.7% vs SPY
-7.9% abs
2026-10-16↗
Jana PartnersSC 13D+1.4M6.3%
-23.2% vs SPY
-18.8% abs
2026-06-29↗
Jana PartnersSC 13D/A−92K5.0%
+11.9% vs SPY
+16.9% abs
2026-05-12↗
Jana PartnersSC 13DNEW5.1%—2026-04-01↗